Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Yamada

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Experimental Lung Research|April 5, 2013
Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitroToru Takahashi, Seiichi Kobayashi, Naoya Fujino, et al.
Respiratory Research|September 26, 2013
The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cellsMitsuhiro Yamada, Hiroshi Kubo, Chiharu Ota, et al.
Respiratory Investigation|February 17, 2016
Receptor for advanced glycation end products expressed on alveolar epithelial cells is the main target for hyperoxia-induced lung injuryChiharu Ota, Kota Ishizawa, Mitsuhiro Yamada, et al.
American Journal of Respiratory and Critical Care Medicine|October 7, 2006
Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinomaSeiichi Kobayashi, Hiroshi Kubo, Takashi Suzuki, et al.
Experimental Lung Research|July 8, 2015
Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivoChiharu Ota, Mitsuhiro Yamada, Naoya Fujino, et al.
BMJ Open|March 8, 2014
Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective studyToru Takahashi, Seiichi Kobayashi, Naoya Fujino, et al.
Thorax|July 31, 2012
Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibilityToru Takahashi, Seiichi Kobayashi, Naoya Fujino, et al.
Medicine|July 12, 2024
The dorsal muscle group area at the T12 vertebral level as a risk factor for tolerability of nintedanib in patients with idiopathic pulmonary fibrosis or other progressive fibrosing interstitial lung diseasesManabu Ono, Seiichi Kobayashi, Hanagama Masakazu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 17, 2010
Isolation of alveolar epithelial type II progenitor cells from adult human lungsNaoya Fujino, Hiroshi Kubo, Takaya Suzuki, et al.
Respiratory Investigation|October 2, 2012
Analysis of gene expression profiles in alveolar epithelial type II-like cells differentiated from human alveolar epithelial progenitor cellsNaoya Fujino, Chiharu Ota, Takaya Suzuki, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Experimental Lung Research|April 5, 2013
Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitroToru Takahashi, Seiichi Kobayashi, Naoya Fujino, et al.
Respiratory Research|September 26, 2013
The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cellsMitsuhiro Yamada, Hiroshi Kubo, Chiharu Ota, et al.
Respiratory Investigation|February 17, 2016
Receptor for advanced glycation end products expressed on alveolar epithelial cells is the main target for hyperoxia-induced lung injuryChiharu Ota, Kota Ishizawa, Mitsuhiro Yamada, et al.
American Journal of Respiratory and Critical Care Medicine|October 7, 2006
Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinomaSeiichi Kobayashi, Hiroshi Kubo, Takashi Suzuki, et al.
Experimental Lung Research|July 8, 2015
Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivoChiharu Ota, Mitsuhiro Yamada, Naoya Fujino, et al.
BMJ Open|March 8, 2014
Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective studyToru Takahashi, Seiichi Kobayashi, Naoya Fujino, et al.
Thorax|July 31, 2012
Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibilityToru Takahashi, Seiichi Kobayashi, Naoya Fujino, et al.
Medicine|July 12, 2024
The dorsal muscle group area at the T12 vertebral level as a risk factor for tolerability of nintedanib in patients with idiopathic pulmonary fibrosis or other progressive fibrosing interstitial lung diseasesManabu Ono, Seiichi Kobayashi, Hanagama Masakazu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 17, 2010
Isolation of alveolar epithelial type II progenitor cells from adult human lungsNaoya Fujino, Hiroshi Kubo, Takaya Suzuki, et al.
Respiratory Investigation|October 2, 2012
Analysis of gene expression profiles in alveolar epithelial type II-like cells differentiated from human alveolar epithelial progenitor cellsNaoya Fujino, Chiharu Ota, Takaya Suzuki, et al.
Pageof 11